Topical treatments for scalp psoriasis-Reference-Cited by-同舟云学术

Topical treatments for scalp psoriasis

Published:2016-02-26 Issue:2 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Schlager Justin Gabriel¹,Rosumeck Stefanie¹,Werner Ricardo Niklas¹,Jacobs Anja²,Schmitt Jochen³,Schlager Christoph⁴,Nast Alexander¹

Affiliation:

1. Charité - Universitätsmedizin Berlin; Division of Evidence Based Medicine, Department of Dermatology, Venerology and Allergology; Charitéplatz 1 Berlin Germany 10117

2. Federal Joint Committee (G-BA, Gemeinsamer Bundesausschuss); Department of Medical Consulting; Wegelystrasse 8 Berlin Germany 10623

3. Faculty of Medicine Carl Gustav Carus, Technischen Universität (TU) Dresden; Center for Evidence-Based Healthcare; Fetscherstr. 74 Dresden Germany 01307

4. The University of Nottingham; c/o Cochrane Skin Group; A103, King's Meadow Campus Lenton Lane Nottingham UK NG7 2NR

Publisher

Wiley

Subject

Pharmacology (medical)

Reference208 articles.

1. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis;Andres;Journal of Drugs in Dermatology,2006

2. Limited benefit of combined use of tar-based shampoo with 50 mug/ml calcipotriol solution in scalp psoriasis;Barrett;Journal of Dermatological Treatment,2005

3. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis;Bergstrom;Cutis,2003

4. A double-blind trial comparing the efficacy and safety of augmented betamethasone dipropionate lotion with fluocinonide solution in the treatment of severe scalp psoriasis;Breneman;Journal of Dermatological Treatment,1992

5. Calcipotriol plus betamethasone dipropionate gel is effective and safe in the treatment of scalp psoriasis (a phase II study). (Abstract P06.57);Buckley;Journal of the European Academy of Dermatology & Venereology,2005

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosing Disorders of Facial Erythema;Dermatologic Clinics;2023-07

2. Real‐world efficacy of adjunctive calcipotriene/betamethasone dipropionate foam for recalcitrant psoriatic lesions on the scalp or lower legs with biologic therapy;The Journal of Dermatology;2023-06-22

3. Lokaltherapie der Psoriasis vulgaris;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-06

4. Topical treatment of psoriasis vulgaris;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-05-26

5. Efficacy and safety of supramolecular active zinc in the treatment of scalp psoriasis: a multicentre, randomized, observed-blind, parallel-group, placebo- and active-controlled noninferiority trial;Clinical and Experimental Dermatology;2023-05-04